Alexza Pharma (ALXA) Files $40M Mixed Shelf
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $40 million of Common Stock, Preferred Stock, Debt Securities, Warrants, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Theravance Biopharma (TBPH) Announces $100M Shares, $150M Conv. Stock Offerings
- Gladstone Capital (GLAD) Plans Common Stock Offering
- Collegium Pharma (COLL) Prices 5M Share Stock Offering for Proceeds of $80M
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!